| scholarly article | Q13442814 |
| P2093 | author name string | Lynn R Webster | |
| Mary Bond | |||
| Maciej Gasior | |||
| Laura Rabinovich-Guilatt | |||
| Yuju Ma | |||
| Richard Malamut | |||
| Kerri A Schoedel | |||
| William Tracewell | |||
| P2860 | cites work | Dose proportionality of a hydrocodone extended-release tablet formulated with abuse-deterrence technology. | Q53565308 |
| Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects | Q85951512 | ||
| Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology | Q89354109 | ||
| Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users | Q34677759 | ||
| Abuse risks and routes of administration of different prescription opioid compounds and formulations | Q35541054 | ||
| Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology | Q36084061 | ||
| Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users | Q37616572 | ||
| Recent advances in the pharmacological management of acute and chronic pain | Q38405649 | ||
| Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations | Q38632934 | ||
| Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers | Q39196678 | ||
| Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene | Q41038100 | ||
| Trends in opioid analgesic abuse and mortality in the United States | Q41583893 | ||
| Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. | Q42222671 | ||
| National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse | Q44335315 | ||
| Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users | Q44337198 | ||
| Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment | Q46716773 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P577 | publication date | 2017-06-14 | |
| P1433 | published in | Pain Medicine | Q15746562 |
| P1476 | title | Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users |
Search more.